Bioactive crystallized glass ceramic comprising wollastonite, hydroxyapatite and diopside, and use thereof
AssigneeCg Bio Co., Ltd.
InventorsBaek-Hyun Kim, Hyun Seung Ryu, Jun Hyuk Seo, Seok Beom Song
Life of this patent
Estimating the term…
Abstract
The present invention relates to a glass ceramic composition comprising SiO2, Ca(OH)2, CaF2, B2O3, MgO, and hydroxyapatite; a bioactive crystallized glass ceramic comprising each of CaSiO3, Ca10(PO4)6(OH)2, and CaMgSi2O6 in an amount of 20% to 60% by weight; an implant for early osseointegration comprising the glass ceramic; and a method for manufacturing the implant.
Claims6
A glass ceramic composition comprising SiO2, Ca(OH)2, CaF2, B2O3, MgO, and hydroxyapatite, and wherein the composition comprises SiO2 in an amount of 15% to 45% by weight, Ca(OH)2 in an amount of 25% to 45% by weight, CaF2 in an amount of 0.01% to 3.5% by weight, B2O3 in an amount of 0.01% to 3.5% by weight of, MgO in an amount of 0.01% to 20% by weight, and hydroxyapatite in an amount of 15% to 45% by weight based on the total weight of the glass ceramic composition.
Dependencies are inferred from the claim text.